Health News

Surveillance May Be Best For Small Kidney Tumors

Date: Feb-13-2013
Surveillance, or the watch and wait approach, may be the best option for older patients with small kidney tumors. The finding came from a large retrospective study which showed that surveillance is a safe alternative to surgery. The research will be presented at the American Society of Clinical Oncology (ASCO) conference on Saturday. The results of the investigation indicated that older patients with small kidney tumors, less than 1...

Coronavirus Person To Person Transmission Occurring In UK

Date: Feb-13-2013
A newly confirmed coronavirus infection in the UK indicates that it occurred as a result of person-to-person infection - the individual has no history of recent travel anywhere and no short- or long-term history of travel to the Middle East, the Health Protection Agency (HPA), UK, announced today. This latest case, involving a UK resident, brings the total number of confirmed coronavirus infection cases worldwide to 11 - three of them in the United Kingdom. Patient number 11 is currently receiving intensive care treatment at The Queen Elizabeth Hospital, Birmingham...

Limit Added Sugars In Beverages - Consumer Group Urges

Date: Feb-13-2013
High levels of sugar or corn syrup in sodas are a major cause of obesity, diabetes, and other health problems, according to the Center for Science in the Public Interest (CSPI).  As part of a strategy to reduce the American population's incredibly high sugar intake, the group, along with many other health-advocacy organizations, are proposing that the FDA strongly considers setting a safe limit on the level of sugar allowed in beverages...

Hospital Readmission And Death Rates Not Strongly Linked

Date: Feb-13-2013
A study of over 3 million hospital admissions reveals that there is no significant association between hospital readmission and mortality rates among Medicare patients who suffer from heart attack, heart failure or pneumonia. The researchers, who published their findings in a recent issue of JAMA, did not find any evidence to suggest that a hospital's mortality rate in 30 days has any link to its readmission rate in 30 days. Improving overall hospital care is vital for policy makers...

Music Lessons Early In Life Increase Brain Development

Date: Feb-13-2013
Playing the recorder in kindergarten, piano lessons in first grade, clapping to the rhythm throughout elementary school music class, all of these can contribute to developing the brain. The new findings, published in the Journal of Neuroscience, reveal that musical training earlier than the age of seven has a significant impact on the development of the brain. Those who began musical training early had more powerful connections between motor regions - the parts of the brain that aid in planning and executing movements...

3rd CMO Quality Oversight And Risk Management Conference, 16-17 April 2013, Boston, MA

Date: Feb-13-2013
"This conference exceeded expectations due to interaction and conversation between presenters and attendees." - QA Manager, Kadmon Pharmaceuticals That's how past participants at the CMO Quality Oversight & Risk Management Conference feel about the speakers and content at this annual Boston, MA conference. Join key decision makers working in quality assurance, external quality and regulation in pharmaceutical, biotechnology companies and CMOs on April 16-17, 2013. Identify strategies to manage and audit CMOs and meet multiple quality and compliance standards...

NICE Issues Preliminary Guidance To Not Recommend Jakavi™ In The Treatment Of Rare Blood Cancer As Not Cost-Effective

Date: Feb-13-2013
Novartis today expressed disappointment at the National Institute for Health and Clinical Excellence's (NICE) preliminary recommendation to not recommend Jakavi™ (INC424, ruxolitinib) for the treatment of disease-related splenomegaly (enlarged spleen) or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post-polycythaemia vera myelofibrosis or post-essential thrombocythaemia myelofibrosis[i]...

Elvanse® (Lisdexamfetamine Dimesylate) Receives UK Marketing Authorisation - New Option For The Treatment Of ADHD In Children And Adolescents

Date: Feb-13-2013
Shire plc (LSE: SHP, NASDAQ: SHPG) have announced that its single-daily dose long-acting prodrug stimulant, Elvanse, has been authorised by the MHRA for the treatment of ADHD in children aged 6 years and over when response to previous methylphenidate treatment is considered clinically inadequate.2 Elvanse is the first stimulant prodrug to be launched in Europe for the treatment of ADHD. It is ingested in an inactive form and subsequently activated within the body, meaning that the active part of Elvanse is gradually released over time...

Study Reveals Effects Of Meningitis And Septicaemia On Learning In School Children

Date: Feb-13-2013
A Meningitis Research Foundation funded study has shown that meningitis and septicaemia have a significant impact on children's school performance. Their ability to learn and their behaviour are especially affected and are worse than for children treated in intensive care with other critical illnesses. The new research, from Imperial College London, conducted at St Mary's and Great Ormond Street hospitals and just published in the journal Critical Care Medicine, looked at children aged 5 to 16 years old who had been in paediatric intensive care...

Discovery Of Novel Targets And Targeting Compounds For Fighting Deadly Infectious Diseases Including MtB

Date: Feb-13-2013
An international team of researchers from India, Brazil, Mexico, the USA, and Denmark led by Debmalya Barh from the Institute of Integrative Omics and Applied Biotechnology (IIOAB) in Nonakuri, Tamluk, Purba Medinipur, West Bengal, India have claimed to have identified a novel drug target (Acetate kinase) common to pathogens causing hemorrhagic diarrohea; tuberculosis, plague diphtheria, and Caseous lymphadenitis and two novel targets (Undecaprenyl pyrophosphate phosphatase enzyme and Outer membrane protein ompU) that may help to develop both a drug and a vaccine against ...